JZL184
Names
Preferred IUPAC name
4-Nitrophenyl 4-[di(2H -1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate
Identifiers
CAS Number
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
UNII
InChI=1S/C27H24N2O9/c30-26(38-21-5-3-20(4-6-21)29(32)33)28-11-9-17(10-12-28)27(31,18-1-7-22-24(13-18)36-15-34-22)19-2-8-23-25(14-19)37-16-35-23/h1-8,13-14,17,31H,9-12,15-16H2
N Key: SEGYOKHGGFKMCX-UHFFFAOYSA-N
N
c1cc(ccc1[N+](=O)[O-])OC(=O)N2CCC(CC2)C(c3ccc4c(c3)OCO4)(c5ccc6c(c5)OCO6)O
Properties
Chemical formula
C27 H24 N2 O9
Molar mass
520.15 g/mol
Appearance
Pale yellow solid
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
JZL184 is an irreversible inhibitor for monoacylglycerol lipase (MAGL), the primary enzyme responsible for degrading the endocannabinoid 2-arachidonoylglycerol (2-AG).[ 1] It displays high selectivity for MAGL over other brain serine hydrolases, including the anandamide -degrading enzyme fatty acid amide hydrolase (FAAH), thereby making it a useful tool for studying the effects of endogenous 2-AG signaling, in vivo . Administration of JZL184 to mice was reported to cause dramatic elevation of brain 2-AG leading to several cannabinoid-related behavioral effects .
See also
References
^ Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF (November 2008). "Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects" . Nat. Chem. Biol . 5 (1): 37– 44. doi:10.1038/nchembio.129 . PMC 2605181 . PMID 19029917 .
Phytocannabinoids (comparison)
Cannabibutols Cannabichromenes Cannabicyclols Cannabidiols Cannabielsoins Cannabigerols Cannabiphorols Cannabinols
CBN
CBNA
CBN-C1
CBN-C2
CBN-C4
CBNM
CBND
CBNP
CBVD
Cannabitriols Cannabivarins Delta-3-tetrahydrocannabinols Delta-4-tetrahydrocannabinols Delta-7-tetrahydrocannabinols Delta-8-tetrahydrocannabinols Delta-9-tetrahydrocannabinols Delta-10-Tetrahydrocannabinols Delta-11-Tetrahydrocannabinols Miscellaneous cannabinoids Active metabolites
Endocannabinoids Synthetic cannabinoid receptor agonists / neocannabinoids
Classical cannabinoids (dibenzopyrans) Non-classical cannabinoids Adamantoylindoles Benzimidazoles Benzoylindoles
1-Butyl-3-(2-methoxybenzoyl)indole
1-Butyl-3-(4-methoxybenzoyl)indole
1-Pentyl-3-(2-methoxybenzoyl)indole
AM-630
AM-679
AM-694
AM-1241
AM-2233
GW-405,833 (L-768,242)
Pravadoline
RCS-4
WIN 54,461
Cyclohexylphenols Eicosanoids
AM-883
AM-1346
ACEA
ACPA
Methanandamide (AM-356)
O-585
O-689
O-1812
O-1860
O-1861
Indazole-3- carboxamides Indole-3-carboxamides Indole-3-carboxylates Naphthoylindazoles Naphthoylindoles Naphthoylpyrroles
JWH-030
JWH-031
JWH-032
JWH-033
JWH-036
JWH-044
JWH-045
JWH-145
JWH-146
JWH-147
JWH-150
JWH-156
JWH-243
JWH-244
JWH-245
JWH-246
JWH-292
JWH-293
JWH-307
JWH-308
JWH-309
JWH-346
JWH-347
JWH-348
JWH-363
JWH-364
JWH-365
JWH-366
JWH-367
JWH-368
JWH-369
JWH-370
JWH-371
JWH-372
JWH-373
Naphthylmethylindenes Naphthylmethylindoles
JWH-175
JWH-184
JWH-185
JWH-192
JWH-194
JWH-195
JWH-196
JWH-197
JWH-199
Phenylacetylindoles Pyrazolecarboxamides Tetramethylcyclo- propanoylindazoles Tetramethylcyclo- propanoylindoles Others
Allosteric CBR Tooltip Cannabinoid receptor ligandsEndocannabinoid enhancers (inactivation inhibitors) Anticannabinoids (antagonists/inverse agonists/antibodies)